Share Email Print
cover

Proceedings Paper

Commercialization of evanescent planar waveguide (EPW) technology
Author(s): Arthur D. Boren; Jan W. Pawlak; Timothy J. Stultz
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Great new product ideas come from many sources including academia, industry and creative entrepreneurs. Combine a solid team of scientists, engineers and business people with diverse, relevant experience with committed investors and those ideas can become reality. The development of the LifeLiteTM System is a case study that began with an academic research program and will culminate in commercial launch in IIQ01 following FDA approval. The LifeLiteTM System is a technology platform with broad application in immunoassays, molecular diagnostics and genomics/proteomics. The first product application is the LifeLiteTM Cardiac Panel, a 5-minute point-of-care test to measure troponin-I, myoglobin and CK-MB in whole blood using a single disposable reagent cartridge. Each cartridge also contains proprietary integral quality controls to check that the instrument and reagents are functioning propertly on every test. No other system offers the superior performance, single cartridge/multi-analyte testing capability and breadth of new product candidates. This paper describes some of the key technical challenges and creative solutions applied by the ThauMDx product development team to apply EPWTM in a commercial product as well as future applications of the platforms.

Paper Details

Date Published: 22 May 2001
PDF: 4 pages
Proc. SPIE 4255, Clinical Diagnostic Systems, (22 May 2001); doi: 10.1117/12.426746
Show Author Affiliations
Arthur D. Boren, ThauMDx (United States)
Jan W. Pawlak, ThauMDx (United States)
Timothy J. Stultz, ThauMDx (United States)


Published in SPIE Proceedings Vol. 4255:
Clinical Diagnostic Systems
Gerald E. Cohn, Editor(s)

© SPIE. Terms of Use
Back to Top